HCRT and Alzheimer disease: Regarding the orexin expression, the results are not entirely consistent: in fact, some have observed a significant reduction in orexin-A levels in AD patients [101], while others (Slats et al. and Liguori et al.)have found no differences in orexin-A levels in the CSF between AD patients and healthy controls [103,164].